A new drug combo recently approved by the Food & Drug Administration can halt lung cancer in its treacherous tracks — for ...

Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it ...

Alongside immunotherapy or chemo, the wearable device helped patients live longer in a trial, though the results are somewhat controversial.

There are no approved therapies to tackle c-Met protein overexpression, AbbVie said in a press release. C-Met is a receptor ...

In new research, a team led by University of Cincinnati researchers has identified a potential new way to make radiation more ...

"Survival rates for lung cancer are still very low compared with other types of the disease and so to see such positive ...

Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune Lua® for ...

Summit Therapeutics shares rose sharply Friday morning, a day after the company said its developmental lung cancer drug was ...

Drug Improves Effectiveness of Radiation for Lung Cancer That Has Spread to the Brain Oct. 4, 2024 — The University of Cincinnati's Debanjan Bhattacharya is first author of new research ...

The University of Cincinnati’s Debanjan Bhattacharya is first author of new research published in Cancers that found the drug ...

In new research, a team led by University ... Prior to this study, AM-101's effect in non-small cell lung cancer was unknown. AM-101 is a particularly useful drug in the context of brain ...